- $127.76m
- $161.55m
- $151.88m
- 72
- 60
- 48
- 62
Annual income statement for DHI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 117 | 111 | 120 | 150 | 152 |
| Cost of Revenue | |||||
| Gross Profit | 104 | 96.9 | 105 | 132 | 132 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 107 | 146 | 122 | 146 | 146 |
| Operating Profit | 10.1 | -34.4 | -1.75 | 3.26 | 5.99 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 9.43 | -35.2 | -1.03 | 3.6 | 3.62 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.63 | -32.4 | -0.402 | 4.18 | 3.49 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 12.6 | -30 | -29.7 | 4.18 | 3.49 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 12.6 | -30 | -29.7 | 4.18 | 3.49 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.155 | -0.119 | 0.046 | 0.128 | 0.163 |